Antimicrobial Susceptibility Testing Market is segmented by Product Type (Manual Antimicrobial Susceptibility Testing Products (Susceptibility Testing Disks, Mic Strips and Susceptibility Plates), Automated Laboratory Instruments and Consumables), by Application Type (Antibacterial, Antifungal, Anti-parasitic, and Antiviral), by Technology Type (Disk Diffusion, Rapid Automated AST, Broth Dilution, Gradient Diffusion, and Genotypic Methods) by Distribution Channel Type (Hospitals, Pathology/Diagnostic Laboratories, Research and Academic Institutes, Pharmaceutical and Biotechnology Companies, and Contract Research Organizations), Region (North America [The USA, Canada, and Mexico], Europe [Germany, France, The U.K., Russia, and Rest of Europe], Asia-Pacific [China, Japan, India, South Korea, and Rest of Asia-Pacific], and Rest of the World [Brazil, Saudi Arabia, Israel, and Others]).

What is an Antimicrobial Susceptibility Testing Market?

Antimicrobial susceptibility testing (AST) validates susceptibility, detects resistance, and informs patient therapy selection. The testing can help doctors choose the right drugs and dosage for difficult-to-treat infections. Antibiotic resistance is a critical global health hazard that requires worldwide action. It has become a huge global health hazard as a result of antibiotic overuse. Current antimicrobial susceptibility testing (AST) procedures, which are used to probe for resistant or nonresistant (susceptible) phenotypes of infections, often take two to one week from the time of sample collection.

Market Dynamics

The antimicrobial susceptibility testing market was estimated at US$ 3.4 billion in 2021 and is expected to grow at a CAGR of 5.86% during 2022-2028 to reach US$ ~6.28 billion in 2028. Over the forecast period, the increased frequency of infectious diseases is expected to fuel the global antimicrobial susceptibility testing market growth. According to the World Health Organization (WHO) Fact Sheet published in October 2021, 1.5 million individuals died from tuberculosis (TB) in 2020 (including 214,000 HIV patients). According to the same source, tuberculosis is the world's 13th leading cause of death and, after COVID-19, the second leading infectious killer.

Get access to a deeper coverage of the impact of COVID-19 on this Market here: https://www.stratviewresearch.com/Request-Sample/3102/antimicrobial-susceptibility-testing-market.html#form

Features of the Report

This report offers high-quality insights and is the outcome of detailed research methodology comprising extensive secondary research, rigorous primary interviews with industry stakeholders and validation and triangulation with Stratview Research’s internal database and statistical tools.

The Antimicrobial Susceptibility Testing Market analysis report discusses the following heads in details:

·       Market structure: Overview, industry life cycle analysis, supply chain analysis.

·       COVID-19 Impact Assessment.

·       Market environment analysis: Growth drivers and constraints, Porter’s five forces analysis, SWOT analysis.

·       Market trend and forecast analysis.

·       Market segment trend and forecast.

·       Competitive landscape and dynamics: Market share, product portfolio, product launches, etc.

·       Attractive market segments and associated growth opportunities.

·       Emerging trends.

·       Strategic growth opportunities for the existing and new players

·       Key success factors.

Segment Analysis

The market is divided based on product, technology, application, and end user. On the basis of product, the market is further segmented into manual antimicrobial susceptibility testing products, automated laboratory instruments and consumables. The market based on manual antimicrobial susceptibility testing products is further segmented into susceptibility testing disks, mic strips and susceptibility plates.

On the basis of application, the market is segmented into antibacterial, antifungal, anti-parasitic, and antiviral.

Based on technology, the antimicrobial susceptibility testing market has been divided into disk diffusion, rapid automated ast, broth dilution, gradient diffusion, and genotypic methods.

On the basis of end user, the market is classified into hospitals, pathology/diagnostic laboratories, research and academic institutes, pharmaceutical and biotechnology companies, and contract research organizations, and others.

The antimicrobial susceptibility testing market is broken down geographically into geographies, namely North America, Europe, Asia-Pacific, and the Rest of the World (RoW).

Custom Research: Stratview research offers custom research services across sectors. In case of any custom research requirement related to market assessment, competitive benchmarking, sourcing and procurement, target screening, and others, please send your inquiry to sales@stratviewresearch.com.